|
TRAF6 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.06099999955356E-07 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.435400E-04 |
| Normal-vs-Stage2 |
2.735600E-03 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
3.416400E-02 |
| Stage1-vs-Stage2 |
7.704400E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.784800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
5.835800E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.38679999997604E-06 |
| Normal-vs-AfricanAmerican |
2.102000E-01 |
| Normal-vs-Asian |
1.53499999999696E-06 |
| Caucasian-vs-AfricanAmerican |
1.456550E-03 |
| Caucasian-vs-Asian |
2.606600E-01 |
| AfricanAmerican-vs-Asian |
1.374980E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.737910E-03 |
| Normal-vs-Female |
3.98209999999954E-05 |
| Male-vs-Female |
1.048450E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.263900E-02 |
| Normal-vs-Extreme_Weight |
2.438700E-04 |
| Normal-vs-Obese |
2.141500E-02 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
4.707200E-01 |
| Normal_Weight-vs-Obese |
1.868810E-01 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
2.532400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
5.443200E-01 |
| Normal-vs-Grade 3 |
4.903200E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
7.611000E-01 |
| Grade 2-vs-Grade 4 |
5.443200E-01 |
| Grade 3-vs-Grade 4 |
4.903200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.99719999999637E-05 |
| Normal-vs-N1 |
6.602900E-03 |
| N0-vs-N1 |
1.021550E-01 |
|
|
